CD86 and thymoma: In Cox regression analysis, the results revealed that CD86 expression was significantly associated with survival rates in five cancer types, i.e., cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), LGG, skin cutaneous melanoma (SKCM), thymoma (THYM) and uveal melanoma (UVM) (Figure 2).